Erythropoietin for subarachnoid hemorrhage: is there a reason for hope?

Giovanni Grasso, Francesco Tomasello

Risultato della ricerca: Article

7 Citazioni (Scopus)

Abstract

Subarachnoid hemorrhage (SAH) associated with a rupturedcerebral aneurysm remains a source of significant morbidityand mortality, not only from the initial hemorrhage butalso from the delayed complications, such as cerebral vasospasmoften severe enough to induce irreversible changes in cerebralperfusion. Several drugs have been developed that have thepotential to limit cerebral vasospasm and delayed ischemicneurologic deficit, thus improving outcome for patients.
Lingua originaleEnglish
pagine (da-a)46-48
Numero di pagine3
RivistaWorld Neurosurgery
Volume77
Stato di pubblicazionePublished - 2012

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Surgery
  • Clinical Neurology

Cita questo